Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Zilu Zhang, Xiaoqian Xu, Qi Wen, Ruoxuan Zhang, Hongru Chen, Minli Hu, Chupeng Zhang, Chuanhe Jiang, Luxiang Wang, Jiayu Huang, Zengkai Pan, Hua Jin, Yanmin Zhao, Wei Shi, Xiao-Dong Mo, Yang Cao, Xiaoxia Hu

Blood (2025) 146 (Supplement 1): 1062.

https://doi.org/10.1182/blood-2025-1062

Published: 2025

Journal Articles

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2025-5297

Published: 2025

Journal Articles

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Jingtao Huang, Jing Zhou, Shixuan Zhang, Ruoxuan Zhang, Zengkai Pan, Luxiang Wang, Chuanhe Jiang, Jiayu Huang, Zilu Zhang, Yanmin Zhao, Yang Cao, Jianmin Wang, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 268.

https://doi.org/10.1182/blood-2024-202762

Published: 2024

Journal Articles

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Zengkai Pan, Yujun Deng, Jingtao Huang, Aijie Huang, Xiong Ni, Lei Gao, Chuanhe Jiang, Luxiang Wang, Zilu Zhang, Quan Gu, Hui Cheng, Jianmin Wang, Hongbo Hu, Xiaoxia Hu

Blood (2024) 144 (Supplement 1): 101.

https://doi.org/10.1182/blood-2024-200811

Published: 2024

Journal Articles

Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition

Alexander Röth, Guangsheng He, Andres Brodsky, Chatree Chai-Adisaksopha, Narcisa Sonia Comia, Anna Gaya, Martin Höglund, Richard J. Kelly, Ahlam Naila Kori, Je-Hwan Lee, Naoshi Obara, Antonio M Risitano, Anita Appius, Leigh Beveridge, Brittany Gentile, Zilu Zhang, Bing Han, Sasha Sreckovic

Blood (2024) 144 (Supplement 1): 2687.

https://doi.org/10.1182/blood-2024-208072

Published: 2024

Journal Articles

IRF4-BLOC1S5, the First Genomic Fusion Gene Identified in the TEMPI Syndrome

Jia Liu, Zilu Zhang, Wenbin Xu, Qing Yu, Ming-Yuan Jia, Yan Hua

Blood (2023) 142 (Supplement 1): 1923.

https://doi.org/10.1182/blood-2023-184488

Published: 2023

Journal Articles

Targeting RBM39-MEK5 Axis Synergizes with Bortezomib to Inhibit Multiple Myeloma Malignancy

Jia Liu, Zilu Zhang, Wenbin Xu, Ming-Yuan Jia, Chengyu Wu, Yan Hua

Blood (2023) 142 (Supplement 1): 4674.

https://doi.org/10.1182/blood-2023-182900

Published: 2023

Journal Articles

Decoding the Immune Landscape of Pathogenic T Cells in Acute Graft-Versus-Host Disease By Single-Cell RNA-Seq

Zengkai Pan, Yujun Deng, Aijie Huang, Zilu Zhang, Luxiang Wang, Hongbo Hu, Jianmin Wang, Xiaoxia Hu

Blood (2022) 140 (Supplement 1): 7636–7637.

https://doi.org/10.1182/blood-2022-165074

Published: 2022

Journal Articles

Results from the First Phase 3 Crovalimab (C5 Inhibitor) Study (COMMODORE 3): Efficacy and Safety in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Hui Liu, Linghui Xia, Jianyu Weng, Fengkui Zhang, Chuan He, Sujun Gao, Jinsong Jia, Alice C. Chang, Pontus Lundberg, Camelia S. Sima, Jane Shi, Zhenyu Xiao, Yuchen Zhang, Zilu Zhang, Rong Fu

Blood (2022) 140 (Supplement 1): 714–716.

https://doi.org/10.1182/blood-2022-162452

Published: 2022

Journal Articles

Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial

Gregory A. Abel, MDMPH, Hajime Uno, PhD, Anna M. Tanasijevic, MPH, Zilu Zhang, MS, Tammy T Hshieh, MD MPH, Clark T Dumontier, MD, Richard Chen, BA, Lee Mozessohn, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Jane Driver, MD MPH

Blood (2019) 134 (Supplement_1): 67.

https://doi.org/10.1182/blood-2019-126158

Published: 2019

Journal Articles

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Marlise Luskin, MDMS, Eric Zhou, PhD, Zilu Zhang, MS, Daniel J. DeAngelo, MD PhD, Richard Stone, MD, Martha Wadleigh, MD, Jacqueline S Garcia, MD, Eric S. Winer, MD, Christopher Recklitis, PhD, Kelsey O'Day, Victoria Lapiana, Ryan Osborn, David P. Steensma, MD, Gregory A. Abel, MDMPH

Blood (2019) 134 (Supplement_1): 4786.

https://doi.org/10.1182/blood-2019-125147

Published: 2019

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Impacts of IPSS-m and conditioning intensity in allogeneic hematopoietic cell transplant for patients with myelodysplasia neoplasms

Distinct prognosis and transplant timing in core-binding factor Acute Myeloid Leukemia

Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition

IRF4-BLOC1S5, the First Genomic Fusion Gene Identified in the TEMPI Syndrome

Targeting RBM39-MEK5 Axis Synergizes with Bortezomib to Inhibit Multiple Myeloma Malignancy

Decoding the Immune Landscape of Pathogenic T Cells in Acute Graft-Versus-Host Disease By Single-Cell RNA-Seq

Results from the First Phase 3 Crovalimab (C5 Inhibitor) Study (COMMODORE 3): Efficacy and Safety in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only